Health & Beauty

You can know whether you are infected with the new crown and influenza viruses in a single test. With the support of the Shanghai Municipal Science and Technology Commission, the "New Coronavirus 2019-nCoV and Influenza A and B Virus Nucleic Acid Combined Detection Kit (Fluorescence PCR Method)" developed and produced by Shanghai Silide Biomedical Technology Co., Ltd. has recently passed the National Drug Supervision The Authority reviewed and was approved for listing. This is China's first COVID-19 combined influenza A and B virus nucleic acid detection kit based on a fluorescent quantitative PCR platform.

Because the clinical symptoms of people infected with the new coronavirus are similar to those of ordinary flu, and the flu may also have imaging lung patches and ground glass shadows, it is difficult to distinguish between the two. At present, if a patient has symptoms of a cold and fever, he must first undergo a new coronavirus nucleic acid test and then a flu virus test. Multiple tests have brought inconvenience to doctors and patients. The advent of the combined detection kit effectively solves the current clinical diagnosis of the new crown and influenza virus infections, and also provides a convenient detection tool for the upcoming autumn and winter influenza high incidence period. In addition to the "two-in-one", the new crown detection sensitivity of this combined detection kit is 5 times higher than the previous product. Chen Caifu, Chief Technology Officer of Ideadi, told reporters that the high sensitivity is because the test kit fully covers the three genes of the new coronavirus (ORF1ab/N/E gene), which is currently one of the products with the most comprehensive coverage of genes for the new coronavirus detection. Because different individuals have different gene expressions after being infected with the new crown, "full coverage" means a higher detection rate and more realistic and reliable test results.

According to the registration inspection report issued by the China Institute for Food and Drug Control, the detection concentration of this combined test kit for the new coronavirus and different types (multiple subtypes) of influenza viruses is better than the national registration and inspection requirements. For the mutant strains listed as special attention by the WHO, including Delta, through bio-analysis and wet experiment verification, the probe is still effective against the above-mentioned mutations, avoiding missed detection caused by the above-mentioned mutations.